Vitamin D and Immune Function
Tóm tắt
Vitamin D metabolizing enzymes and vitamin D receptors are present in many cell types including various immune cells such as antigen-presenting-cells, T cells, B cells and monocytes. In vitro data show that, in addition to modulating innate immune cells, vitamin D also promotes a more tolerogenic immunological status. In vivo data from animals and from human vitamin D supplementation studies have shown beneficial effects of vitamin D on immune function, in particular in the context of autoimmunity. In this review, currently available data are summarized to give an overview of the effects of vitamin D on the immune system in general and on the regulation of inflammatory responses, as well as regulatory mechanisms connected to autoimmune diseases particularly in type 1 diabetes mellitus.
Từ khóa
Tài liệu tham khảo
Bouillon, 2008, Vitamin D and human health: Lessons from vitamin D receptor null mice, Endocr. Rev., 29, 726, 10.1210/er.2008-0004
Hewison, 2012, An update on vitamin D and human immunity, Clin. Endocrinol., 76, 315, 10.1111/j.1365-2265.2011.04261.x
Weick, 1967, A history of rickets in the United States, Am. J. Clin. Nutr., 20, 1234, 10.1093/ajcn/20.11.1234
Walker, 2009, The vitamin D connection to pediatric infections and immune function, Pediatr. Res., 65, 106R, 10.1203/PDR.0b013e31819dba91
Battault, 2013, Vitamin D metabolism, functions and needs: From science to health claims, Eur. J. Nutr., 52, 429, 10.1007/s00394-012-0430-5
Hewison, 2001, Vitamin D as a cytokine and hematopoetic factor, Rev. Endocr. Metab. Disord., 2, 217, 10.1023/A:1010015013211
2006, Vitamin D in foods and as supplements, Prog. Biophys. Mol. Biol., 92, 33, 10.1016/j.pbiomolbio.2006.02.017
Wacker, 2013, Vitamin D—Effects on skeletal and extraskeletal health and the need for supplementation, Nutrients., 5, 111, 10.3390/nu5010111
Calvo, 2005, Overview of the proceedings from Experimental Biology 2004 symposium: Vitamin D insufficiency: A significant risk factor in chronic diseases and potential disease-specific biomarkers of vitamin D sufficiency, J. Nutr., 135, 301, 10.1093/jn/135.2.301
Tripkovic, 2012, Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: A systematic review and meta-analysis, Am. J. Clin. Nutr., 95, 1357, 10.3945/ajcn.111.031070
Wang, 2010, Common genetic determinants of vitamin D insufficiency: A genome-wide association study, Lancet, 376, 180, 10.1016/S0140-6736(10)60588-0
Ponsonby, 2007, The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude, Environ. Health Perspect., 115, 1132, 10.1289/ehp.9937
Andersen, 2013, Seasonal changes in vitamin D status among Danish adolescent girls and elderly women: The influence of sun exposure and vitamin D intake, Eur. J. Clin. Nutr., 67, 270, 10.1038/ejcn.2013.3
Pittaway, 2013, Make vitamin D while the sun shines, take supplements when it doesn’t: A longitudinal, observational study of older adults in Tasmania, Australia, PLoS One, 8, e59063, 10.1371/journal.pone.0059063
Danai, 2007, Seasonal variation in the epidemiology of sepsis, Crit. Care Med., 35, 410, 10.1097/01.CCM.0000253405.17038.43
White, 2009, Let the sun shine in: Effects of ultraviolet radiation on invasive pneumococcal disease risk in Philadelphia, Pennsylvania, BMC Infect. Dis., 9, 196, 10.1186/1471-2334-9-196
Heaney, 2012, Vitamin D-baseline status and effective dose, N. Engl. J. Med., 367, 77, 10.1056/NEJMe1206858
Baeke, 2010, Vitamin D: Modulator of the immune system, Curr. Opin. Pharmacol., 10, 482, 10.1016/j.coph.2010.04.001
Heaney, 2011, Assessing vitamin D status, Curr. Opin. Clin. Nutr. Metab. Care, 14, 440, 10.1097/MCO.0b013e328348ed85
Ross, 2011, The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know, JCEM, 96, 53, 10.1210/jc.2010-2704
(2010). Dietary Reference Intakes for Calcium and Vitamin D.
Holick, 2011, Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline, JCEM, 96, 1911, 10.1210/jc.2011-0385
(2012). EFSA Panel on Dietetic Products Nutrition and Allergies Scientific Opinion on the Tolerable Upper Intake Level of vitamin D1. EFSA J., 10, 1–45.
Vieth, 2007, Vitamin D toxicity, policy, and science, J. Bone Miner. Res., 22, 64, 10.1359/jbmr.07s221
Zittermann, 2013, Safety issues of vitamin D supplementation, Anticancer Agents Med. Chem., 13, 4, 10.2174/187152013804487290
Vieth, 1990, The mechanisms of vitamin D toxicity, Bone Miner., 11, 267, 10.1016/0169-6009(90)90023-9
Vieth, 2006, Critique of the considerations for establishing the tolerable upper intake level for vitamin D: Critical need for revision upwards, J. Nutr., 136, 1117, 10.1093/jn/136.4.1117
Jones, 2008, Pharmacokinetics of vitamin D toxicity, Am. J. Clin. Nutr., 88, 582, 10.1093/ajcn/88.2.582S
Lowe, 2011, Vitamin D toxicity due to a commonly available “over the counter” remedy from the Dominican Republic, JCEM, 96, 291, 10.1210/jc.2010-1999
(2009). KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int., S1–S130.
Shoback, 2008, Clinical practice. Hypoparathyroidism, N. Engl. J. Med., 359, 391, 10.1056/NEJMcp0803050
Bilezikian, 2011, Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future reseach, J. Bone Miner. Res., 26, 2317, 10.1002/jbmr.483
Mantovani, 2011, Clinical review: Pseudohypoparathyroidism: Diagnosis and treatment, JCEM, 96, 3020, 10.1210/jc.2011-1048
Grad, 2004, Cod and the consumptive: A brief history of cod-liver oil in the treatment of pulmonary tuberculosis, Pharm. Hist., 46, 106
Wang, 2004, Cutting edge: 1,25-Dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression, J. Immunol., 173, 2909, 10.4049/jimmunol.173.5.2909
Gombart, 2005, Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3, FASEB J., 19, 1067, 10.1096/fj.04-3284com
White, 2012, Vitamin D metabolism and signaling in the immune system, Rev. Endocr. Metab. Disord., 13, 21, 10.1007/s11154-011-9195-z
Liu, 2006, Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response, Science, 311, 1770, 10.1126/science.1123933
Edfeldt, 2010, T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism, Proc. Natl. Acad. Sci. USA, 107, 22593, 10.1073/pnas.1011624108
Ramanathan, 2002, Cathelicidins: Microbicidal activity, mechanisms of action, and roles in innate immunity, Microbes Infect., 4, 361, 10.1016/S1286-4579(02)01549-6
Cowland, 1997, An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma, J. Immunol. Methods, 206, 53, 10.1016/S0022-1759(97)00084-7
Jeng, 2009, Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis, J. Transl. Med., 7, 28, 10.1186/1479-5876-7-28
Gombart, 2009, Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis, Clin. Infect. Dis., 48, 418, 10.1086/596314
Laaksi, 2007, An association of serum vitamin D concentrations <40 nmol/L with acute respiratory tract infection in young Finnish men, Am. J. Clin. Nutr., 86, 714, 10.1093/ajcn/86.3.714
Ginde, 2009, Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey, Arch. Intern. Med., 169, 384, 10.1001/archinternmed.2008.560
Cannell, 2008, Cod liver oil, vitamin A toxicity, frequent respiratory infections, and the vitamin D deficiency epidemic, Ann. Otol. Rhinol. Laryngol., 117, 864, 10.1177/000348940811701112
Cannell, 2006, Epidemic influenza and vitamin D, Epidemiol. Infect., 134, 1129, 10.1017/S0950268806007175
Black, 2005, Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey, Chest, 128, 3792, 10.1378/chest.128.6.3792
Janssens, 2010, Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene, Thorax, 65, 215, 10.1136/thx.2009.120659
Litonjua, 2007, Is vitamin D deficiency to blame for the asthma epidemic?, J. Allergy Clin. Immunol., 120, 1031, 10.1016/j.jaci.2007.08.028
Dimeloe, 2010, Regulatory T cells, inflammation and the allergic response: The role of glucocorticoids and vitamin D, J. Steroid Biochem. Mol. Biol., 120, 86, 10.1016/j.jsbmb.2010.02.029
Murdoch, 2012, Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: The VIDARIS randomized controlled trial, JAMA, 308, 1333, 10.1001/jama.2012.12505
Camargo, 2012, Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia, Pediatrics, 130, e561, 10.1542/peds.2011-3029
Bergman, P., Norlin, A.-C., Hansen, S., Rekha, R.S., Agerberth, B., Björkhem-Bergman, L., Ekström, L., Lindh, J.D., and Andersson, J. (2012). Vitamin D3 supplementation in patients with frequent respiratory tract infections: A randomised and double-blind intervention study. BMJ Open, 2.
Rigby, 1992, Decreased accessory cell function and costimulatory activity by 1,25-dihydroxyvitamin D3-treated monocytes, Arthritis Rheum., 35, 110, 10.1002/art.1780350117
Mora, 2008, Vitamin effects on the immune system: Vitamins A and D take centre stage, Nat. Rev. Immunol., 8, 685, 10.1038/nri2378
Penna, 2007, 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells, J. Immunol., 178, 145, 10.4049/jimmunol.178.1.145
Veldman, 2000, Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system, Arch. Biochem. Biophys., 374, 334, 10.1006/abbi.1999.1605
Ferreira, 2011, 1,25-Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo, Diabetes Metab. Res. Rev., 27, 933, 10.1002/dmrr.1275
Diamant, 1991, Inhibition of production and function of interleukin-6 by 1,25-dihydroxyvitamin D3, Immunol. Lett., 28, 115, 10.1016/0165-2478(91)90108-M
Adorini, 2003, Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases, J. Cell. Biochem., 88, 227, 10.1002/jcb.10340
Griffin, 2001, Dendritic cell modulation by 1α,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo, Proc. Natl. Acad. Sci. USA, 98, 6800, 10.1073/pnas.121172198
Panda, 2001, Targeted ablation of the 25-hydroxyvitamin D 1a-hydroxylase enzyme: Evidence for skeletal, reproductive , and immune dysfunction, Proc. Natl. Acad. Sci. USA, 98, 7498, 10.1073/pnas.131029498
Enioutina, 2009, TLR-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses, J. Immunol., 182, 4296, 10.4049/jimmunol.0804344
Coussens, 2012, Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment, Proc. Natl. Acad. Sci. USA, 109, 15449, 10.1073/pnas.1200072109
Provvedini, 1983, 1,25-Dihydroxyvitamin D3 receptors in human leukocytes, Science, 221, 1181, 10.1126/science.6310748
Lemire, 1984, 1a,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells, J. Clin. Investig., 74, 657, 10.1172/JCI111465
Chen, 2007, Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation, J. Immunol., 179, 1634, 10.4049/jimmunol.179.3.1634
Mahon, 2003, The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells, J. Cell. Biochem., 89, 922, 10.1002/jcb.10580
Lemire, 1985, 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro, J. Immunol., 134, 3032, 10.4049/jimmunol.134.5.3032
Cantorna, 2011, Mechanisms underlying the effect of vitamin D on the immune system, Proc. Nutr. Soc., 69, 286, 10.1017/S0029665110001722
Baeke, 2011, The vitamin D analog, TX527, promotes a human CD4+CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation, J. Immunol., 186, 132, 10.4049/jimmunol.1000695
Lemire, 1995, Immunosuppressive actions of 1,25-dihydroxyvitamin D3: Preferential inhibition of Th1 functions, J. Nutr., 125, 1704S
Gysemans, 2011, Vitamin D in autoimmune, infectious and allergic diseases: A vital player?, Best Pract. Res. Clin. Endocrinol. Metab., 25, 617, 10.1016/j.beem.2011.04.009
Palmer, 2011, Lineage-specific effects of 1,25-dihydroxyvitamin D3 on the development of effector CD4 T cells, J. Biol. Chem., 286, 997, 10.1074/jbc.M110.163790
Giulietti, 2004, Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice, Diabetologia, 47, 451, 10.1007/s00125-004-1329-3
Boonstra, 2001, 1α,25-dihydroxyvitamin D3 has a direct effect on naive CD4+T cells to enhance the development of Th2 cells, J. Immunol., 167, 4974, 10.4049/jimmunol.167.9.4974
Penna, 2006, Diabetic mice by the vitamin D receptor agonist elocalcitol 1, J. Immunol., 177, 8504, 10.4049/jimmunol.177.12.8504
Joshi, 2011, 1,25-Dihydroxyvitamin D3 ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A, Mol. Cell. Biol., 31, 3653, 10.1128/MCB.05020-11
Jeffery, 2009, 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3, J. Immunol., 183, 5458, 10.4049/jimmunol.0803217
Rudensky, 2011, Regulatory T cells and foxP3, Immunol. Rev., 241, 260, 10.1111/j.1600-065X.2011.01018.x
Barrat, 2002, In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1 )- and Th2-inducing cytokines, J. Exp. Med., 195, 603, 10.1084/jem.20011629
Ardalan, 2007, Calcitriol started in the donor, expands the population of CD4+ CD25+ T cells in renal transplant recipients, Transplant. Proc., 39, 951, 10.1016/j.transproceed.2007.04.012
Prietl, 2010, Vitamin D supplementation and regulatory T cells in apparently healthy subjects: Vitamin D treatment for autoimmune diseases?, Isr. Med. Assoc. J., 12, 136
Bock, 2011, The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: A randomized controlled trial, Diabetes Metab. Res. Rev., 25, 942, 10.1002/dmrr.1276
Gabbay, 2012, Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual β-cell function in new-onset type 1 diabetes mellitus, Arch. Pediatr. Adolesc. Med., 166, 601, 10.1001/archpediatrics.2012.164
Zittermann, 2009, Vitamin D and the adaptive immune system with special emphasis to allergic reactions and allograft rejection, Inflamm. Allergy Drug Targets, 8, 161, 10.2174/187152809788462644
Becker, 2001, The common genetic hypothesis of autoimmune/inflammatory disease, Curr. Opin. Allergy. Clin. Immunol., 1, 399, 10.1097/00130832-200110000-00004
Moroni, 2012, Geoepidemiology, gender and autoimmune disease, Autoimmun. Rev., 11, A386, 10.1016/j.autrev.2011.11.012
Zittermann, 2003, Vitamin D in preventive medicine: Are we ignoring the evidence?, Br. J. Nutr., 89, 552, 10.1079/BJN2003837
Cantorna, 2004, Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system, Am. J. Clin. Nutr., 80, 1717, 10.1093/ajcn/80.6.1717S
Antico, 2012, Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature, Autoimmun. Rev., 12, 127, 10.1016/j.autrev.2012.07.007
Reunanen, 2001, Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study, Lancet, 358, 1500, 10.1016/S0140-6736(01)06580-1
2010, Vitamin D and increasing incidence of type 1 diabetes-evidence for an association?, Diabetes Obes. Metab., 12, 737, 10.1111/j.1463-1326.2010.01211.x
Littorin, 2006, Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: Results from the nationwide Diabetes Incidence Study in Sweden (DISS), Diabetologia, 49, 2847, 10.1007/s00125-006-0426-x
Takiishi, 2010, Vitamin D and diabetes, Endocrinol. Metab. Clin. North. Am., 39, 419, 10.1016/j.ecl.2010.02.013
Zipitis, 2008, Vitamin D supplementation in early childhood and risk of type 1 diabetes: A systematic review and meta-analysis, Arch. Dis. Child., 93, 512, 10.1136/adc.2007.128579
(1999). Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia, 42, 51–54.
Gregori, 2002, A 1α,25-dihydroxyvitamin D3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice, Diabetes, 51, 1367, 10.2337/diabetes.51.5.1367
Mathieu, 1994, Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3, Diabetologia, 37, 552, 10.1007/BF00403372
Driver, 2008, Comparative therapeutic effects of orally administered 1,25-dihydroxyvitamin D3 and 1α-hydroxyvitamin D3 on type-1 diabetes in non-obese diabetic mice fed a normal-calcaemic diet, Clin. Exp. Immunol., 151, 76, 10.1111/j.1365-2249.2007.03537.x
Walter, 2010, No effect of the 1α,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes, Diabetes Care, 33, 1443, 10.2337/dc09-2297
Bizzarri, 2010, No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: The IMDIAB XIII trial, Diabetes Care, 33, 1962, 10.2337/dc10-0814
Bailey, 2007, Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes, Diabetes, 56, 2616, 10.2337/db07-0652
Li, 2009, Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA), Diabetes Metab. Res. Rev., 25, 411, 10.1002/dmrr.977
Pitocco, 2006, The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI), Diabet. Med., 23, 920, 10.1111/j.1464-5491.2006.01921.x
Munger, 2006, Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis, JAMA, 296, 2832, 10.1001/jama.296.23.2832
Kragt, 2009, Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women, Mult. Scler., 15, 9, 10.1177/1352458508095920
Munger, 2004, Vitamin D intake and incidence of multiple sclerosis, Neurology, 62, 60, 10.1212/01.WNL.0000101723.79681.38
Aivo, 2012, A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis, J. Neurol. Neurosurg. Psychiatr., 83, 565, 10.1136/jnnp-2011-301876
Stein, 2011, A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis, Neurology, 77, 1611, 10.1212/WNL.0b013e3182343274
Kampman, 2012, Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: Exploratory outcomes from a double-blind randomised controlled trial, Mult. Scler., 18, 1144, 10.1177/1352458511434607
Chang, 2010, 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis, PLoS One, 5, e12925, 10.1371/journal.pone.0012925
Smolders, 2009, Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis, PLoS One, 4, e6635, 10.1371/journal.pone.0006635
Royal, 2009, Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis, J. Neuroimmunol., 213, 135, 10.1016/j.jneuroim.2009.05.012